Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 10/20 | 0.39 |
| ▸ | AURKA | O14965 | 1/20 | 0.39 |
| ▸ | TPX2 | Q9ULW0 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.38 |
| ▸ | SCN1A | P35498 | 2/20 | 0.38 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.37 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.37 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.36 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28716842 | 0.98 | MAOB (0.41) | KIF11MAOBAOC3SCN5AAURKA | |
| SCHEMBL23041308 | 0.89 | MAOB (0.42) | KIF11MAOBAOC3SCN5ANISCH | |
| SCHEMBL24180475 | 0.78 | DHODH (0.49) | KIF11ADORA1KCNH2SCN10A | |
| SCHEMBL24401763 | 0.77 | AURKA (0.41) | KIF11SCN5AAURKATPX2NISCH | |
| SCHEMBL1242144 | 0.77 | KIF11 (0.52) | KIF11SCN5AAURKATPX2NISCH | |
| SCHEMBL23042011 | 0.76 | KIF11 (0.37) | KIF11MAOBAOC3SCN5AAURKA | |
| SCHEMBL29067283 | 0.75 | ALOX5AP (0.42) | KIF11MAOBAOC3SCN5AAURKA | |
| Hydrochloric Acid SCHEMBL29386875 | 0.75 | KIF11 (0.50) | KIF11SCN5AAURKATPX2NISCH | |
| SCHEMBL7938385 | 0.74 | KIF11 (0.50) | KIF11SCN5AAURKATPX2NISCH | |
| SCHEMBL30046979 | 0.74 | AKR1C2 (0.44) | KIF11MAOBAOC3SCN5AAURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4022007-B1 | AROMATIC ISOTHIOCYANATES | MERCK PATENT GMBH (DE) | 2024-04-03 | — | — | EP | disclosed |
| US-11739265-B2 | Aromatic isothiocyanates | MERCK PATENT GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| US-11739265-B2 | Aromatic isothiocyanates | MERCK PATENT GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| US-20220306938-A1 | AROMATIC ISOTHIOCYANATES | MERCK PATENT GMBH (DE) | 2022-09-29 | — | — | US | disclosed |
| EP-4022007-A1 | AROMATIC ISOTHIOCYANATES | Merck Patent GmbH (DE) | 2022-07-06 | — | — | EP | disclosed |
| WO-2021037962-A1 | AROMATIC ISOTHIOCYANATES | MERCK PATENT GMBH (DE) | 2021-03-04 | — | — | WO | disclosed |
| WO-2021037962-A1 | AROMATIC ISOTHIOCYANATES | MERCK PATENT GMBH (DE) | 2021-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220306938-A1 | AROMATIC ISOTHIOCYANATES | TRPA1, CRY1, FOXM1 | KIF11 721/4885MAOB 2493/4885AOC3 1464/4885 |
| US-11739265-B2 | Aromatic isothiocyanates | TRPA1, CRY1, FOXM1 | KIF11 721/4885MAOB 2493/4885AOC3 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.